Eustace, A., Mani, N., Span, P., Irlam, J., Taylor, J., Betts, G., . . . West, C. (2013). A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
Chicago-Zitierstil (17. Ausg.)Eustace, A., et al. A 26-gene Hypoxia Signature Predicts Benefit from Hypoxia-modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. 2013.
MLA-Zitierstil (9. Ausg.)Eustace, A., et al. A 26-gene Hypoxia Signature Predicts Benefit from Hypoxia-modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.